During the past decade, CMiP - Centro Mineiro de Pesquisa conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 19 clinical trials were completed, i.e. on average, 82.6% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 15 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CMiP - Centro Mineiro de Pesquisa" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Genentech, Inc." with 4 trials sponsored, "Pfizer" with 4 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored and "Janssen Research & Development, LLC" with 3 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CMiP - Centro Mineiro de Pesquisa" #1 collaborator was "OCT Clinical Trials" with 3 trials as a collaborator, "Quintiles, Inc." with 3 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator, "IQVIA Pvt. Ltd" with 1 trials as a collaborator and "Mene Research" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "CMiP - Centro Mineiro de Pesquisa" are "Rheumatoid Arthritis" (7 trials), "Juvenile Idiopathic Arthritis" (3 trials), "Systemic Lupus Erythematosus" (3 trials), "Arthritis, Psoriatic" (2 trials) and "Arthritis, Rheumatoid" (2 trials). Many other conditions were trialed in "CMiP - Centro Mineiro de Pesquisa" in a lesser frequency.

Most popular intervention types in "CMiP - Centro Mineiro de Pesquisa" are "Drug" (27 trials), "Biological" (3 trials), "Other" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "GDC-0853" (4 trials), "Tocilizumab" (3 trials), "Baricitinib" (2 trials) and "Guselkumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "CMiP - Centro Mineiro de Pesquisa" are 29 trials for "All" genders.

Currently, there are NaN active trials in "CMiP - Centro Mineiro de Pesquisa". undefined are not yet recruiting, 7 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in CMiP - Centro Mineiro de Pesquisa, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in CMiP - Centro Mineiro de Pesquisa, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".